Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_3
2
40%
Ph phase_4
1
20%
Ph phase_2
1
20%
Ph phase_1
1
20%

Phase Distribution

1

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 32 (40.0%)
Phase 41 (20.0%)

Trials by Status

unknown120%
completed360%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_3

CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections

NCT03236987
completedphase_2

Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis

NCT03160638
unknownphase_3

Hydroxychloroquine, Azithromycin in the Treatment of Covid-19

NCT04405921
completedphase_1

A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin

NCT01416350
completedphase_4

AZISAST Study: AZIthromycin in Severe ASThma Study

NCT00760838

Clinical Trials (5)

Showing 5 of 5 trials
NCT03236987Phase 3

CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections

Recruiting
NCT03160638Phase 2

Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis

Completed
NCT04405921Phase 3

Hydroxychloroquine, Azithromycin in the Treatment of Covid-19

Unknown
NCT01416350Phase 1

A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin

Completed
NCT00760838Phase 4

AZISAST Study: AZIthromycin in Severe ASThma Study

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5